{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T13:48:40Z","timestamp":1792763320742,"version":"4.5.0"},"reference-count":91,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T00:00:00Z","timestamp":1772668800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Newborn screening (NBS) programs began in the 1960s in the US and Europe. Systematically offered at birth, these programs enable the early detection of serious, rare, inherited diseases, facilitating timely treatment and improving survival rates. The range of detectable diseases has expanded significantly, with inclusion criteria evolving since the programs\u2019 inception. Recent advances in genomics now allow for the detection of all DNA variant, enabling the identification of conditions typically diagnosed later in life and\/or for which no effective treatment or preventive interventions are currently available. This expansion raises ethical and psychosocial concerns.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To explore the psychosocial challenges associated with the expansion of NBS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Between May 2022 and March 2024, a global scoping review was conducted using three databases and gray literature. PRISMA guidelines were followed, and thematic analysis was applied to synthesize findings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of 623 articles identified between 1997 and 2024, 68 met inclusion criteria, with nine additional gray literature references, for a total of 77 publications. Most studies originated from North America (\n                      <jats:italic>n<\/jats:italic>\n                      \u202f=\u202f45) and Europe (\n                      <jats:italic>n<\/jats:italic>\n                      \u202f=\u202f26), predominantly in healthcare sciences (\n                      <jats:italic>n<\/jats:italic>\n                      \u202f=\u202f41), particularly medicine (\n                      <jats:italic>n<\/jats:italic>\n                      \u202f=\u202f29), and in humanities and social sciences (\n                      <jats:italic>n<\/jats:italic>\n                      \u202f=\u202f23), especially psychology (\n                      <jats:italic>n<\/jats:italic>\n                      \u202f=\u202f14). The literature mainly addressed parents\u2019 experiences during the early years following an abnormal NBS result; few studies explored healthcare professionals\u2019 or patients\u2019 perspectives. Three core thematic categories were identified: (1) parents\u2019 experience of abnormal results and the impact on parent\u2013child relationships; (2) strategies to mitigate psychosocial risks, including professional and public education; and (3) challenges related to NBS expansion.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>These themes were interpreted as higher-level psychosocial constructs: (1) anxious and depressive dimensions of parental responses; (2) Vulnerable Child Syndrome as a construct shaping parental perceptions and caregiving practices; and (3) psychosocial implications of NBS expansion. Parental anxiety and depression were the most studied outcomes, particularly following abnormal or false-positive results. Current professional training and public education appear insufficient given rapid NBS evolution. Viewing NBS as a continuous process within family\u2013healthcare relationships may help mitigate psychosocial risks.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Further research in psychology and social sciences is critical to better understand and address psychosocial risks, particularly for late-onset conditions and those without current treatment or prevention options.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpsyg.2025.1564032","type":"journal-article","created":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T13:21:43Z","timestamp":1772716903000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Psychosocial issues of neonatal screening in the context of its major expansion: a scoping review"],"prefix":"10.3389","volume":"16","author":[{"given":"Anne-Laure","family":"S\u00e9bert","sequence":"first","affiliation":[{"name":"Research Center for Psychoanalysis, Medicine and Society (EA 3522), Labex \u201cWho am I?\u201d, Department of Psychoanalysis, Institute of Humanities, Sciences and Societies, University Paris-Cit\u00e9","place":["Paris, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcela","family":"Gargiulo","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Psychology, Psychopathology, and Psychoanalysis (UR 4056), Institute of Psychology, University Paris-Cit\u00e9","place":["Paris, France"]},{"name":"Department of Neuromyology, Pitit\u00e9-Salp\u00eatri\u00e8re Hospital Group, Assistance Publique-H\u00f4pitaux de Paris, Institute of Myologie","place":["Paris, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascale","family":"De Lonlay","sequence":"additional","affiliation":[{"name":"Reference Center for Inherited Metabolic Diseases, Necker Enfants Malades Hospital, Assistance Publique\u2013H\u00f4pitaux de Paris, INEM, Fili\u00e8re G2M","place":["Paris, France"]},{"name":"MetabERN (European Reference Network for Hereditary Metabolic Disorders)","place":["Paris, France"]},{"name":"INSERM-1151, INEM","place":["Paris, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Baptiste","family":"Arnoux","sequence":"additional","affiliation":[{"name":"Reference Center for Inherited Metabolic Diseases, Necker Enfants Malades Hospital, Assistance Publique\u2013H\u00f4pitaux de Paris, INEM, Fili\u00e8re G2M","place":["Paris, France"]},{"name":"MetabERN (European Reference Network for Hereditary Metabolic Disorders)","place":["Paris, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Vaiman","sequence":"additional","affiliation":[{"name":"Cochin Institute, U1016 INSERM, UMR 8104 CNRS, University Paris-Cit\u00e9","place":["Paris, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Bensimon","sequence":"additional","affiliation":[{"name":"Research Center for Psychoanalysis, Medicine and Society (EA 3522), Labex \u201cWho am I?\u201d, Department of Psychoanalysis, Institute of Humanities, Sciences and Societies, University Paris-Cit\u00e9","place":["Paris, France"]},{"name":"Reference Center for Inherited Metabolic Diseases, Necker Enfants Malades Hospital, Assistance Publique\u2013H\u00f4pitaux de Paris, INEM, Fili\u00e8re G2M","place":["Paris, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Araneda","sequence":"additional","affiliation":[{"name":"Research Center for Psychoanalysis, Medicine and Society (EA 3522), Labex \u201cWho am I?\u201d, Department of Psychoanalysis, Institute of Humanities, Sciences and Societies, University Paris-Cit\u00e9","place":["Paris, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,5]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1038\/gim.2012.87","article-title":"Factors associated with knowledge of and satisfaction with newborn screening education: a survey of mothers","volume":"14","author":"Araia","year":"2012","journal-title":"Genet. Med."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1080\/1364557032000119616","article-title":"Scoping studies: towards a methodological framework","volume":"8","author":"Arksey","year":"2005","journal-title":"Int. J. Soc. Res. Methodol."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1093\/jpepsy\/jsn032","article-title":"Supporting family adaptation to presymptomatic and \"untreatable\" conditions in an era of expanded newborn screening","volume":"34","author":"Bailey","year":"2009","journal-title":"J. Pediatr. Psychol."},{"key":"ref4","first-page":"143","article-title":"Cystic fibrosis newborn screening: impact of early screening results on parenting stress","volume":"23","author":"Baroni","year":"1997","journal-title":"Pediatr. Nurs."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3917\/lcp.250.0030","article-title":"Une recherche-action autour du processus d\u2019annonce de la ph\u00e9nylc\u00e9tonurie: entre dispositif de sant\u00e9 publique et retentissements psychiques","volume":"250","author":"Bensimon","year":"2022","journal-title":"Le Carnet PSY"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s10875-020-00886-4","article-title":"Parents' perspectives and societal acceptance of implementation of newborn screening for SCID in the Netherlands","volume":"41","author":"Blom","year":"2021","journal-title":"J. Clin. Immunol."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3917\/cont.047.0031","article-title":"Le conseil g\u00e9n\u00e9tique","volume":"47","author":"Bordet","year":"2018","journal-title":"Contraste"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3390\/ijns8040059","article-title":"Parental depression and anxiety associated with newborn bloodspot screening for rare and variable-onset disorders","volume":"8","author":"Boychuk","year":"2022","journal-title":"Int. J. Neonatal Screen"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1191\/1478088706qp063oa","article-title":"Using thematic analysis in psychology","volume":"3","author":"Braun","year":"2006","journal-title":"Qual. Res. Psychol."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3390\/ijns8020035","article-title":"Experiences of families caring for children with newborn screening-related conditions: implications for the expansion of genomics in population-based neonatal public health programs","volume":"8","author":"Bush","year":"2022","journal-title":"Int. J. Neonatal Screen"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/ajmg.a.20031","article-title":"Parental attitudes regarding newborn screening of PKU and DMD","author":"Campbell","year":"2003","journal-title":"Am. J. Med. Genet. A"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1007\/s10897-018-0227-7","article-title":"Parenting a child with phenylketonuria (PKU): an interpretative phenomenological analysis (IPA) of the experience of parents","volume":"27","author":"Carpenter","year":"2018","journal-title":"J. Genet. Couns."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"S22","DOI":"10.1016\/j.pedneo.2022.11.001","article-title":"The modern face of newborn screening","volume":"64","author":"Chien","year":"2023","journal-title":"Pediatr. Neonatol."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1007\/s10897-016-9959-4","article-title":"Parents\u2019 experiences of receiving the initial positive newborn screening (NBS) result for cystic fibrosis and sickle cell disease","volume":"25","author":"Chudleigh","year":"2016","journal-title":"J. Genet. Couns."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1002\/mus.24880","article-title":"Twenty-year follow-up of newborn screening for patients with muscular dystrophy","volume":"53","author":"Chung","year":"2016","journal-title":"Muscle Nerve"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.prrv.2019.02.003","article-title":"Newborn screening for cystic fibrosis: is there benefit for everyone?","volume":"31","author":"Course","year":"2019","journal-title":"Paediatr. Respir. Rev."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3390\/ijns8030043","article-title":"A qualitative study: mothers' experiences of their child's late-onset Pompe disease diagnosis following newborn screening","volume":"8","author":"Crossen","year":"2022","journal-title":"Int. J. Neonatal Screen"},{"key":"ref18","year":"2025"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1080\/10810730590904580","article-title":"Uncertainty management following a positive newborn screening for cystic fibrosis","volume":"10","author":"Dillard","year":"2005","journal-title":"J. Health Commun."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1080\/02739610701766867","article-title":"Psychosocial aspects of newborn screening programs for cystic fibrosis","volume":"37","author":"Duff","year":"2008","journal-title":"Child. Health Care"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1159\/000534648","article-title":"Call to action for advancing equitable genomic newborn screening","volume":"26","author":"Ersig","year":"2023","journal-title":"Public Health Genomics"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.pec.2012.10.024","article-title":"Frequency of high-quality communication behaviors used by primary care providers of heterozygous infants after newborn screening","volume":"90","author":"Farrell","year":"2008","journal-title":"Patient Educ. Couns."},{"key":"ref23","first-page":"221","article-title":"Improving communication between doctors and parents after newborn screening","volume":"110","author":"Farrell","year":"2011","journal-title":"WMJ"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1001\/archpediatrics.2007.55","article-title":"Assessment of parental understanding by pediatric residents during counseling after newborn genetic screening","volume":"162","author":"Farrell","year":"2008","journal-title":"Arch. Pediatr. Adolesc. Med."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1542\/peds.2004-2611","article-title":"Content of communication by pediatric residents after newborn genetic screening","volume":"116","author":"Farrell","year":"2005","journal-title":"Pediatrics"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jpeds.2020.03.027","article-title":"Experience with parent follow-up for communication outcomes after newborn screening identifies carrier status","volume":"224","author":"Farrell","year":"","journal-title":"J. Pediatr."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.jpeds.2020.03.042","article-title":"Vulnerable child syndrome and newborn screening carrier results for cystic fibrosis or sickle cell","volume":"224","author":"Farrell","year":"","journal-title":"J. Pediatr."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1007\/s10995-015-1869-9","article-title":"Evaluating harms in the assessment of net benefit: a framework for newborn screening condition review","volume":"20","author":"Goldenberg","year":"2016","journal-title":"Matern. Child Health J."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3390\/ijns8010011","article-title":"Genomics and newborn screening: perspectives of public health programs","volume":"8","author":"Goldenberg","year":"2022","journal-title":"Int. J. Neonatal Screen"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta8330","article-title":"Psychosocial aspects of genetic screening of pregnant women and newborns: a systematic review","volume":"8","author":"Green","year":"2004","journal-title":"Health Technol. Assess."},{"key":"ref31","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1542\/peds.34.1.58","article-title":"Reactions to the threatened loss of a child: a vulnerable child syndrome. Pediatric management of the dying child, part III","volume":"34","author":"Green","year":"1964","journal-title":"Pediatrics"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"S72","DOI":"10.1002\/hast.1019","article-title":"Qualitative research on expanded prenatal and newborn screening: robust but marginalized","volume":"49","author":"Grob","year":"2019","journal-title":"Hast. Cent. Rep."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"S29","DOI":"10.1002\/hast.881","article-title":"Families' experiences with newborn screening: a critical source of evidence","volume":"48","author":"Grob","year":"2018","journal-title":"Hast. Cent. Rep."},{"key":"ref9002","first-page":"1","article-title":"Newborn screening for cystic fibrosis: evaluation of benefits and risks and recommendations for state newborn screening programs","volume":"53","author":"Grosse","year":"2004","journal-title":"MMWR Recomm Rep."},{"key":"ref9001","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.jcv.2009.08.019","article-title":"Newborn screening for congenital cytomegalovirus: options for hospital-based and public health programs","volume":"46","author":"Grosse","year":"2009","journal-title":"J Clin Virol."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.jpeds.2017.01.049","article-title":"Psychosocial response to uncertain newborn screening results for cystic fibrosis","volume":"184","author":"Hayeems","year":"2017","journal-title":"J. Pediatr."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"e20161052","DOI":"10.1542\/peds.2016-1052","article-title":"Parent experience with false-positive newborn screening results for cystic fibrosis","volume":"138","author":"Hayeems","year":"2016","journal-title":"Pediatrics"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1111\/j.1399-0004.2007.00783.x","article-title":"Newborn screening for mucopolysaccharidoses: opinions of patients and their families","volume":"71","author":"Hayes","year":"2007","journal-title":"Clin. Genet."},{"key":"ref37","year":"2024"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1007\/s10545-006-0381-1","article-title":"A review of the psychosocial effects of false-positive results on parents and current communication practices in newborn screening","volume":"29","author":"Hewlett","year":"2006","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref39","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3390\/ijns5020023","article-title":"Psychological impact on parents of an inconclusive diagnosis following newborn bloodspot screening for cystic fibrosis: a qualitative study","volume":"5","author":"Johnson","year":"2019","journal-title":"Int. J. Neonatal Screen"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1038\/s41431-022-01054-5","article-title":"Receiving results of uncertain clinical relevance from population genetic screening: systematic review & meta-synthesis of qualitative research","volume":"30","author":"Johnson","year":"2022","journal-title":"Eur. J. Hum. Genet."},{"key":"ref41","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13023-016-0391-5","article-title":"The health system impact of false positive newborn screening results for medium-chain acyl-CoA dehydrogenase deficiency: a cohort study","volume":"11","author":"Karaceper","year":"2016","journal-title":"Orphanet J. Rare Dis."},{"key":"ref42","doi-asserted-by":"publisher","first-page":"100742","DOI":"10.1016\/j.eclinm.2021.100742","article-title":"\"We needed this\": perspectives of parents and healthcare professionals involved in a pilot newborn screening program for spinal muscular atrophy","volume":"33","author":"Kariyawasam","year":"2021","journal-title":"EClinicalMedicine"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1080\/0142159X.2020.1755030","article-title":"Thematic analysis of qualitative data: AMEE guide no. 131","volume":"42","author":"Kiger","year":"2020","journal-title":"Med. Teach."},{"key":"ref44","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.3390\/children9121829","article-title":"Parental burden and quality of life in 5q-SMA diagnosed by newborn screening","volume":"9","author":"K\u00f6lbel","year":"2022","journal-title":"Children (Basel)"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.prrv.2019.02.009","article-title":"The implications and management of cystic fibrosis screen positive, inconclusive diagnosis patients","volume":"31","author":"Krishnananthan","year":"2019","journal-title":"Paediatr. Respir. Rev."},{"key":"ref46","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1542\/peds.2005-0449","article-title":"Initially misleading communication of carrier results after newborn genetic screening","volume":"116","author":"La Pean","year":"2005","journal-title":"Pediatrics"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"e202101016","DOI":"10.4321\/S1135-57272021000100001","article-title":"Medio siglo de cribado neonatal en Espa\u00f1a: evoluci\u00f3n de los aspectos \u00e9ticos, legales y sociales (AELS). Parte III, aspectos sociales","volume":"95","author":"Labrador Ca\u00f1adas","year":"2021","journal-title":"Rev. Esp. Salud Publica"},{"key":"ref9003","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1542\/peds.2018-1099B","article-title":"Ethical and psychosocial issues in whole genome sequencing (WGS) for newborns","volume":"143","author":"Lantos","year":"2019","journal-title":"Pediatrics."},{"key":"ref9004","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3917\/eres.schne.2006.01.0157","article-title":"D\u00e9pistage positif de la surdit\u00e9 n\u00e9onatale permanente et profil interactif des dyades m\u00e8re-enfant","volume-title":"Enfant en d\u00e9veloppement, famille et handicaps","author":"Le Driant","year":"2006"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3390\/ijns7010002","article-title":"Ethical and psychosocial implications of genomic newborn screening","volume":"7","author":"Levy","year":"2021","journal-title":"Int. J. Neonatal Screen"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.prrv.2023.04.002","article-title":"Psychosocial needs and interventions for young children with cystic fibrosis and their families","volume":"46","author":"Li","year":"2023","journal-title":"Paediatr. Respir. Rev."},{"key":"ref50","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1097\/GIM.0b013e3181b3a61e","article-title":"Impact of false-positive newborn metabolic screening results on early health care utilization","volume":"11","author":"Lipstein","year":"2009","journal-title":"Genet. Med."},{"key":"ref51","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1002\/jgc4.1421","article-title":"Opinions of adults affected with later-onset lysosomal storage diseases regarding newborn screening: a qualitative study","volume":"30","author":"Lisi","year":"2021","journal-title":"J. Genet. Couns."},{"key":"ref52","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3390\/ijns6040084","article-title":"Development of strategies to decrease false positive results in newborn screening","volume":"6","author":"Malvagia","year":"2020","journal-title":"Int. J. Neonatal Screen"},{"key":"ref53","year":"2024"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.jcf.2006.09.001","article-title":"Newborn screening for CF in a regional paediatric centre: the psychosocial effects of false-positive IRT results on parents","volume":"6","author":"Moran","year":"2007","journal-title":"J. Cyst. Fibros."},{"key":"ref55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12874-018-0611-x","article-title":"Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach","volume":"18","author":"Munn","year":"2018","journal-title":"BMC Med. Res. Methodol."},{"key":"ref56","year":"2024"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1007\/s10897-014-9740-5","article-title":"Disparities in current and future childhood and newborn carrier identification","volume":"23","author":"Noke","year":"2014","journal-title":"J. Genet. Couns."},{"key":"ref58","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41431-017-0069-z","article-title":"Psychosocial impact on mothers receiving expanded newborn screening results","volume":"26","author":"O'Connor","year":"2018","journal-title":"Eur. J. Hum. Genet."},{"key":"ref59","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"Bmj"},{"key":"ref60","first-page":"e202203030","article-title":"Cribado neonatal gen\u00f3mico. Perspectiva de la Comisi\u00f3n de \u00e9tica de la Asociaci\u00f3n Espa\u00f1ola de Gen\u00e9tica Humana. Parte II: Aspectos \u00c9ticos, Legales y Sociales (AELS) de la Introducci\u00f3n de las Tecnolog\u00edas de Secuenciaci\u00f3n Masiva (NGS) en un programa de cribado neonatal de Salud P\u00fablica","volume":"96","author":"P\u00e0mpols Ros","year":"2022","journal-title":"Rev. Esp. Salud Publica"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/s1526-0542(03)00086-1","article-title":"Psychosocial issues in newborn screening for cystic fibrosis","volume":"4","author":"Parsons","year":"2003","journal-title":"Paediatr. Respir. Rev."},{"key":"ref62","doi-asserted-by":"publisher","first-page":"F91","DOI":"10.1136\/fn.86.2.f91","article-title":"Newborn screening for Duchenne muscular dystrophy: a psychosocial study","volume":"86","author":"Parsons","year":"2002","journal-title":"Arch. Dis. Child. Fetal Neonatal Ed."},{"key":"ref63","doi-asserted-by":"publisher","first-page":"F467","DOI":"10.1136\/fn.88.6.f467","article-title":"Implications of carrier identification in newborn screening for cystic fibrosis","volume":"88","author":"Parsons","year":"2003","journal-title":"Arch. Dis. Child. Fetal Neonatal Ed."},{"key":"ref64","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1001\/jamapediatrics.2021.2829","article-title":"Psychosocial effect of newborn genomic sequencing on families in the BabySeq project: a randomized clinical trial","volume":"175","author":"Pereira","year":"2021","journal-title":"JAMA Pediatr."},{"key":"ref65","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1111\/j.1651-2227.2009.01485.x","article-title":"Inconclusive cystic fibrosis neonatal screening results: long-term psychosocial effects on parents","volume":"98","author":"Perobelli","year":"2009","journal-title":"Acta Paediatr."},{"key":"ref66","first-page":"3","article-title":"Methodology for JBI scoping reviews","volume-title":"The Joanna Briggs institute reviewers manual 2015","author":"Peters","year":"2015"},{"key":"ref67","first-page":"141","article-title":"Guidance for the conduct of JBI scoping reviews","volume-title":"Joanna Briggs institute reviewer's manual","author":"Peters","year":"2017"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1002\/jgc4.1615","article-title":"Newborn screening for Pompe disease: parental experiences and follow-up care for a late-onset diagnosis","volume":"31","author":"Prakash","year":"2022","journal-title":"J. Genet. Couns."},{"key":"ref69","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1007\/s10545-018-0159-2","article-title":"Newborn screening for Pompe disease: impact on families","volume":"41","author":"Pruniski","year":"2018","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref70","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/s12883-015-0473-3","article-title":"Understanding the experiences and needs of individuals with spinal muscular atrophy and their parents: a qualitative study","volume":"15","author":"Qian","year":"2015","journal-title":"BMC Neurol."},{"key":"ref71","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s10897-017-0150-3","article-title":"Psychosocial distress and knowledge deficiencies in parents of children in Ireland who carry an altered cystic fibrosis gene","volume":"27","author":"Quigley","year":"2018","journal-title":"J. Genet. Couns."},{"key":"ref72","first-page":"423","volume-title":"Soi-m\u00eame comme un autre","author":"Ricoeur","year":"1990"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/s0002-7138(09)62188-9","article-title":"Iatrogenesis: the PKU anxiety syndrome","volume":"7","author":"Rothenberg","year":"1968","journal-title":"J. Am. Acad. Child Psychiatry"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1177\/16094069231156344","article-title":"A scoping review and reflexive thematic analysis of lived experiences in photovoice studies","volume":"33","author":"Smith","year":"2023","journal-title":"J. Qual. Health Res."},{"key":"ref75","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3917\/empa.083.0079","article-title":"R\u00e9flexions sur l'annonce du diagnostic pr\u00e9coce de surdit\u00e9","volume":"83","author":"Soriano","year":"2011","journal-title":"Empan"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1038\/s41576-023-00621-w","article-title":"Genomic newborn screening for rare diseases","volume":"24","author":"Stark","year":"2023","journal-title":"Nat. Rev. Genet."},{"key":"ref77","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1471-2288-8-45","article-title":"Methods for the thematic synthesis of qualitative research in systematic reviews","volume":"8","author":"Thomas","year":"2008","journal-title":"BMC Med. Res. Methodol."},{"key":"ref78","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1177\/0022146510386794","article-title":"Patients-in-waiting: living between sickness and health in the genomics era","volume":"51","author":"Timmermans","year":"2010","journal-title":"J. Health Soc. Behav."},{"key":"ref79","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3390\/ijns8040053","article-title":"Psychosocial issues related to newborn screening: a systematic review and synthesis","volume":"8","author":"Tluczek","year":"2022","journal-title":"Int. J. Neonatal Screen"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1542\/peds.2004-0275","article-title":"Psychosocial risk associated with newborn screening for cystic fibrosis: parents' experience while awaiting the sweat-test appointment","volume":"115","author":"Tluczek","year":"2005","journal-title":"Pediatrics"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.jcf.2013.10.001","article-title":"Long-term follow-up of cystic fibrosis newborn screening: psychosocial functioning of adolescents and young adults","volume":"13","author":"Tluczek","year":"2014","journal-title":"J. Cyst. Fibros."},{"key":"ref9005","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1177\/1049732310382919","article-title":"Psychosocial consequences of false-positive newborn screens for cystic fibrosis","volume":"21","author":"Tluczek","year":"2011","journal-title":"Qual Health Res."},{"key":"ref82","doi-asserted-by":"publisher","first-page":"e36235","DOI":"10.1371\/journal.pone.0036235","article-title":"Psychological effects of false-positive results in expanded newborn screening in China","volume":"7","author":"Tu","year":"2012","journal-title":"PLoS One"},{"key":"ref83","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3917\/dec.kehr.2011.01.0159","article-title":"Qualit\u00e9 de vie ou vie de qualit\u00e9? D\u00e9pister une maladie g\u00e9n\u00e9tique","volume-title":"De la vie biologique \u00e0 la vie sociale. Approches sociologiques et anthropologiques","author":"Vailly","year":"2011"},{"key":"ref84","doi-asserted-by":"publisher","first-page":"706394","DOI":"10.3389\/fped.2021.706394","article-title":"Expanding neonatal bloodspot screening: a multi-stakeholder perspective","volume":"9","author":"Van Dijk","year":"2021","journal-title":"Front. Pediatr."},{"key":"ref85","doi-asserted-by":"crossref","DOI":"10.1145\/2601248.2601268","article-title":"Guidelines for snowballing in systematic literature studies and a replication in software engineering","volume-title":"Proc 18th Int Conf Eval Assess Softw Eng.","author":"Wohlin","year":"2014"},{"key":"ref86","year":"2024"}],"container-title":["Frontiers in Psychology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyg.2025.1564032\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T13:21:46Z","timestamp":1772716906000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyg.2025.1564032\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,5]]},"references-count":91,"alternative-id":["10.3389\/fpsyg.2025.1564032"],"URL":"https:\/\/doi.org\/10.3389\/fpsyg.2025.1564032","relation":{},"ISSN":["1664-1078"],"issn-type":[{"value":"1664-1078","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,5]]},"article-number":"1564032"}}